For the price of a weekend trip, your genetic bl

New launch pairs Abbott’s over-the-counter con

New authority will regulate Dubai’s longevity

New approval for ultra-rare blood cancer highlig

As Canada approaches super-aged status, Manulife

Biogen has agreed to acquire RayThera Inc.

Scribe Therapeutics has been awarded more than $2

Insilico and SK Biopharmaceuticals have agreed a

Nuritas will exhibit plant-based peptide hydrolys

Beacon Biosignals participated in SLEEP 2026, eng

Greenstone Biosciences, Inc. and Intel Corp.

Positive Phase 1b results for ATX-304 suggest sc

Positive Phase 1b results for ATX-304 suggest sc

Phase 2 trial of leramistat targets sarcopenia,

Australian healthtech Everlab has raised $42 mil

New funding will support development of regenera

Stress-enduring cells offer a precision, homing-

Insilico Medicine announced completion of first-i

Oligomerix has received a $1.

Cambrian Bio presented Phase 1b human translation

NorthStrive Biosciences, a PMGC Holdings Inc.

Designs for Health launched Akkermansia Pro GLP-1

BPGbio presented clinical and translational findi

A once-daily patch could make one of pulmonary a

New data suggest MS 001 could help preserve musc

LNS8801 advances into the National Institute on

Dan DeBaun, founder of the largest authorized Be

A one-time CRISPR treatment dramatically reduced

Cognition Therapeutics announced on 16 June 2026

AlzeCure announced on 16 June 2026, that its Phas

Resolution Therapeutics has expanded its inflamma

ProJenX provided a development update for Proseti

Hangzhou Qihan Biotech announced that its off-the

Everlab has closed an oversubscribed AU$65 millio

LG AI Research signed a master agreement with D&D

Gero announced $17 million in new financing, brin

New supplement combines creatine, HMB and pomegr

A study from Muna Therapeutics suggests the brai

Non-invasive continuous hormone monitoring arriv

Men’s health company adds physician-prescribed

Stealth BioTherapeutics Holdings Inc.

Immorta Bio and TAM Global announced a preclinica

Restore Hyper Wellness, based in Austin, Texas, l

Telomir Pharmaceuticals announced the peer-review

BioAge Labs has dosed the first participant in QU

New financing backs a physics-based approach tha

New Longevity Science Foundation campaign aims t

Phase 2 study will assess whether RJx-01 can imp

New Michael J Fox Foundation grant backs a two-p

Alzheimer’s research may be entering its next